Skip to main content
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
36.99
-1.05 (-2.76%)
At close: Mar 28, 2025, 4:00 PM
35.44
-1.55 (-4.19%)
Pre-market: Mar 31, 2025, 8:53 AM EDT

CRISPR Therapeutics AG Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Collaboration
35.00M - - - 370.00M - 170.10M 100.26M
Collaboration Growth
-90.54% - - - 84,762.39% - 1,207.15% -89.02%
Grant
2.31M 2.83M 2.23M 1.71M 1.21M - - -
Grant Growth
91.87% - - - - - - -

Operating Expense Breakdown
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Research and Development
320.65M 333.64M 342.18M 363.57M 387.33M 395.74M 421.67M 443.34M
Research and Development Growth
-17.22% -15.69% -18.85% -17.99% -16.10% -14.19% -1.49% 14.51%
Collaboration
- 130.25M 142.52M 135.02M 130.25M 117.07M 132.51M 121.80M
Collaboration Growth
- 11.26% 7.55% 10.86% 18.14% -13.44% 11.49% 8.86%
General and Administrative
72.98M 71.33M 72.20M 71.76M 76.16M 80.85M 89.56M 96.80M
General and Administrative Growth
-4.18% -11.77% -19.38% -25.88% -25.67% -22.98% -11.92% -7.11%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.